NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← Tirzepatide vendors

LumiraTirzepatide

13 testslatest 14 Sept 2026$0.74/mg median
Visit websitepeptaura.comIntelligence report23 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold
Free peptide testing

Ordered Tirzepatide from Lumira? Mail in a sample (US only) and let us test it for free.

Test my supply
+16 more ↓
77%
Finnrick rating
#157 of 262 Tirzepatide vendors
10 of 13 classifiable tests passed
customers 4.5★ (12)
methodology · Purity focus
Finnrick analysis · Tirzepatide

An early 99.1% purity miss weighs on an improving record; later tests clear the purity bar, while -21% underfills still fit this purity-focus method's wide fill tolerance. Batch IDs are absent; the signal rests on recent identity/purity.

methodology →
vendor intelligence report
Vendor Intelligence Report: Lumira

Domain and contact records tie Lumira to the Welon/Peptidecube stack while US-shipping language points another way. The report maps privacy-protected domains, referral-code promotion, and payment/refund friction.

23 pages6 risk factors assessed2 Jul 2026
read the report
Peptides
24 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.10
93%
11
2
Tirzepatideselected
$0.74
77%
13
3
Retatrutide
$1.70
77%
26
4
Ipamorelin
$1.37
57%
4
5
GLOW
$0.57
50%
3
6
Tesamorelin
$3.40
48%
8
7
TB-500
$2.45
43%
5
8
BPC-157
$1.18
43%
5
9
hCG
-
39%
4
10
HGH
-
38%
3
11
CJC-1295
$1.79
33%
1
12
MOTS-c
$1.22
26%
3
13
NAD+
$0.03
19%
5
14
Wolverine
$1.76
0%
3
15
CJC-IPA
$1.79
-
0
16
DSIP
$0.96
-
0
17
Epithalon
$0.64
-
0
18
Glutathione
$0.01
-
0
19
KPV
$0.95
-
0
20
Melanotan II
$0.82
-
0
21
Pinealon
$0.90
-
0
22
PT-141
$1.11
-
0
23
Sermorelin
$3.88
-
0
24
SS-31
$0.30
-
0
Contact channels
2 channels on file
Websitepeptaura.comEmailorders@peptaura.com
Rating trend
Tirzepatide from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%28 Apr 2026: 80%28 Apr 2026: 76%5 May 2026: 77%5 Jun 2026: 78%12 Jun 2026: 79%12 Jun 2026: 81%15 Jun 2026: 82%30 Jul 2026: 82%5 Aug 2026: 83%18 Aug 2026: 84%27 Aug 2026: 80%7 Sep 2026: 77%14 Sep 2026: 78%29 Sep 2026: current 77%80%82%77%Apr 26Sep 26
Showing Tirzepatide tests only
Free peptide testing

Ordered Tirzepatide from Lumira? Mail in a sample (US only) and let us test it for free.

Test my supply
Lumira Tirzepatide test history
13 tests · 10 pass · 3 fail
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
14 Sep 2026Pass
bbmwcy2
Tested
lab nameView COA
7 Sep 2026Fail
tyrxyve
Tested
lab nameView COA
27 Aug 2026Fail
bwpvjbz
Tested
lab nameView COA
18 Aug 2026Pass
ydzyx3u
Tested
lab nameView COA
5 Aug 2026Pass
cxbstdn
Tested
lab nameView COA
30 Jul 2026Pass
fmcz7wk
Tested
lab nameView COA
15 Jun 2026Pass
e5yq5bh
Tested
lab nameView COA
12 Jun 2026Pass
dsaaqne
Tested
lab nameView COA
12 Jun 2026Pass
2mu47d6
Tested
lab nameView COA
5 Jun 2026Pass
psgpwr8
Tested
lab nameView COA
1-10 of 13

About Lumira test results from Finnrick

Lumira is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 14 peptides and 94 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Lumira peptides in this dataset are BPC-157 (5 tests), CJC-1295 (1 test) and GHK-Cu (11 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 94 recent tests. It also includes 2 corrections related to this vendor.

Corrections
2 corrections
2026-08-04
Lab correction
The original Certificate of Analysis (COA 209392) incorrectly identified the sample as **Tirzepatide** instead of the correct compound, **BPC-157**. The testing laboratory subsequently reissued the Certificate of Analysis as **COA 209656**, correcting the sample identification. The updated COA has been used to replace the incorrect information.
2026-07-26
Finnrick data entry
The COA data was corrected from 56.8 to 568 following identification of a probable parsing error during data extraction. As a result of this correction, the calculated score was updated from 3.5 to 4.1.
Free peptide testing

Ordered Tirzepatide from Lumira? Mail in a sample (US only) and let us test it for free.

Test my supply